Cargando…

Treg cells in the course of chronic hepatitis C virus infection partially normalize in longitudinal observation after successful DAA treatment regardless of hepatic fibrosis stage

AIM OF THE STUDY: Elevated circulating CD4+ CD25+ Foxp3+ regulatory T cells in patients with chronic hepatitis C (CHC) play an unspecified role in liver fibrosis development. This study aimed to determine whether Treg cells diminish after successful treatment with directacting antivirals (DAA) in pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zientarska, Agata, Kaczmarek, Mariusz, Mozer-Lisewska, Iwona, Kowala-Piaskowska, Arleta, Witkowska, Aleksandra, Żeromski, Jan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2021
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8284172/ https://www.ncbi.nlm.nih.gov/pubmed/34295988 http://dx.doi.org/10.5114/ceh.2021.107122

Ejemplares similares

Gender as a factor affecting NK cell activity in patients successfully treated for chronic hepatitis C with direct-acting antivirals
por: Zientarska, Agata, et al.
Publicado: (2021)

Impact of chronic HCV treatment on quality of life of patients with metabolic disorders in context of immunological disturbances
por: Kierepa, Agata, et al.
Publicado: (2020)

Significance and Role of Pattern Recognition Receptors in Malignancy
por: Żeromski, Jan, et al.
Publicado: (2019)

Correction to: Significance and Role of Pattern Recognition Receptors in Malignancy
por: Żeromski, Jan, et al.
Publicado: (2019)

Pattern Recognition Receptors: Significance of Expression in the Liver
por: Żeromski, Jan, et al.
Publicado: (2020)

Genetic (KIR, HLA-C) and Some Clinical Parameters Influencing the Level of Liver Enzymes and Early Virologic Response in Patients with Chronic Hepatitis C
por: Mozer-Lisewska, Iwona, et al.
Publicado: (2015)

Detection and Significance of Cytotoxic Cell Subsets in Biopsies of HCV-Infected Human Livers
por: Mozer-Lisewska, Iwona, et al.
Publicado: (2013)

Significance of Toll-like Receptors Expression in Tumor Growth and Spreading: A Short Review
por: Zeromski, Jan, et al.
Publicado: (2008)

Changes in Inflammatory Markers after Administration of Tocilizumab in COVID-19: A Single-Center Retrospective Study
por: Olewicz-Gawlik, Anna, et al.
Publicado: (2021)

Alterations in NK Cell Phenotype in Relation to Liver Steatosis in Children with Chronic Hepatitis C
por: Mania, Anna, et al.
Publicado: (2013)

Pneumocystis pneumonia in children – the relevance of chemoprophylaxis in different groups of immunocompromised and immunocompetent paediatric patients
por: Zajac-Spychała, Olga, et al.
Publicado: (2015)

Self-reactive IgE and anti-IgE therapy in autoimmune diseases
por: Olewicz-Gawlik, Anna, et al.
Publicado: (2023)

Syphilis and HIV infection in patients with hepatitis A: a preliminary study from one centre in Poland
por: Bura, Maciej, et al.
Publicado: (2020)

Alterations of insulin-like growth factor I (IGF-I) and estradiol serum levels in chronic hepatitis C
por: Adamek, Agnieszka, et al.
Publicado: (2012)

Prevalence of IFNL3 rs4803217 single nucleotide polymorphism and clinical course of chronic hepatitis C
por: Świątek-Kościelna, Bogna, et al.
Publicado: (2017)

Treatment of hepatitis C in HIV patients in the new DAA era
por: Soriano, Vicente
Publicado: (2014)

Treatment of hepatitis C virus genotype 4 in the DAA era
por: Di Biagio, Antonio, et al.
Publicado: (2018)

258 Analysis of the Hepatic Microenvironment Before and After Direct-Acting Antiviral (DAA) Therapy for Viral Hepatitis C
por: Millian, Daniel, et al.
Publicado: (2023)

Chronic Hepatitis C Association with Diabetes Mellitus and Cardiovascular Risk in the Era of DAA Therapy
por: Drazilova, Sylvia, et al.
Publicado: (2018)

“Waiting for DAAs”: A retrospective chart review of patients with untreated hepatitis C in Rwanda
por: Gupta, Neil, et al.
Publicado: (2017)

Perceived Stress in Hepatitis C Virus Infected Patients under the DAA-Based Therapy
por: Danilescu, Claudia Monica, et al.
Publicado: (2022)

Higher expression of inhibitory CD158b and CD158e NK cell receptor and age predicts treatment response in children with chronic hepatitis C
por: Mania, Anna, et al.
Publicado: (2017)

Telehealth for Hepatitis C Care in the DAA Era; Ensuring Everyone Can Access a Cure
por: Schulz, Thomas Ray, et al.
Publicado: (2017)

Drug Resistance Profile and Clinical Features for Hepatitis C Patients Experiencing DAA Failure in Taiwan
por: Hong, Chun-Ming, et al.
Publicado: (2021)

Behandlung von Hepatitis-C-Infektionen im Zeitalter direkt wirkender antiviraler Medikamente (DAAs)
por: Peiffer, Kai-Henrik, et al.
Publicado: (2022)

Depressive and Anxious Symptoms in Hepatitis C Virus Infected Patients Receiving DAA-Based Therapy
por: Danilescu, Claudia Monica, et al.
Publicado: (2021)

A real-life study of the positive response to DAA-based therapies for hepatitis C in Brazil
por: Vivaldini, Simone Monzani, et al.
Publicado: (2021)

Immune responses in DAA treated chronic hepatitis C patients with and without prior RG-101 dosing
por: van der Ree, Meike H., et al.
Publicado: (2017)

Molecular Mechanisms of Resistance to Direct-Acting Antiviral (DAA) Drugs for the Treatment of Hepatitis C Virus Infections
por: Izhari, Mohammad Asrar
Publicado: (2023)

Hepatic vein obstruction is the most common type of hepatic venous outflow obstruction regardless of socioeconomic status
por: Shukla, Akash, et al.
Publicado: (2015)

Early View of the Effectiveness of New Direct-Acting Antiviral (DAA) Regimens in Patients with Hepatitis C Virus (HCV)
por: Walker, David R., et al.
Publicado: (2015)

Hepatocellular carcinoma occurrence in DAA-treated hepatitis C virus patients: Correlated or incidental? A brief review
por: Gigi, Eleni, et al.
Publicado: (2018)

Liver and cardiovascular mortality after hepatitis C virus eradication by DAA: Data from RESIST‐HCV cohort
por: Calvaruso, Vincenza, et al.
Publicado: (2021)

Modeling-Based Response-Guided DAA Therapy for Chronic Hepatitis C to Identify Individuals for Shortening Treatment Duration
por: Goyal, Ashish, et al.
Publicado: (2022)

Hepatic Steatosis Index in Acromegaly: Correlation with Insulin Resistance Regardless of the Disease Control
por: Ciresi, Alessandro, et al.
Publicado: (2018)

Study of changes in lipid profile and insulin resistance in Egyptian patients with chronic hepatitis C genotype 4 in the era of DAAs
por: El Sagheer, Ghada, et al.
Publicado: (2018)

Introduction of the second-generation direct-acting antivirals (DAAs) in chronic hepatitis C: a register-based study in Sweden
por: Frisk, P., et al.
Publicado: (2018)

Poor Outcomes of Acute Hepatitis E in Patients With Cirrhotic Liver Diseases Regardless of Etiology
por: Wang, Yijin, et al.
Publicado: (2020)

Substance‐use simulation impairs driving capability in patients with cirrhosis regardless of hepatic encephalopathy
por: Acharya, Chathur, et al.
Publicado: (2022)

Agreement and reproducibility of radiological signs in NEC using The Duke Abdominal Assessment Scale (DAAS)
por: Markiet, Karolina, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_c2nqn676g8lpa5nmkim0uiguq8